Stage-specific roles of microbial dysbiosis and metabolic disorders in rheumatoid arthritis.
Stage-specific roles of microbial dysbiosis and metabolic disorders in rheumatoid arthritis.
复制标题
微生物失调和代谢紊乱在类风湿性关节炎中的阶段特异性作用
DOI:
10.1136/ard-2022-222871
复制
发表时间:
2022-08-19
影响因子:
27.4
通讯作者:
中科院分区:
文献类型:
--
作者:
Rheumatoid arthritis (RA) is a progressive disease including four stages, where gut microbiome is associated with pathogenesis. We aimed to investigate stage-specific roles of microbial dysbiosis and metabolic disorders in RA. We investigated stage-based profiles of faecal metagenome and plasma metabolome of 76 individuals with RA grouped into four stages (stages I–IV) according to 2010 RA classification criteria, 19 individuals with osteroarthritis and 27 healthy individuals. To verify bacterial invasion of joint synovial fluid, 16S rRNA gene sequencing, bacterial isolation and scanning electron microscopy were conducted on another validation cohort of 271 patients from four RA stages. First, depletion of Bacteroides uniformis and Bacteroides plebeius weakened glycosaminoglycan metabolism (p<0.001), continuously hurting articular cartilage across four stages. Second, elevation of Escherichia coli enhanced arginine succinyltransferase pathway in the stage II and stage III (p<0.001), which was correlated with the increase of the rheumatoid factor (p=1.35×10–3) and could induce bone loss. Third, abnormally high levels of methoxyacetic acid (p=1.28×10–8) and cysteine-S-sulfate (p=4.66×10–12) inhibited osteoblasts in the stage II and enhanced osteoclasts in the stage III, respectively, promoting bone erosion. Fourth, continuous increase of gut permeability may induce gut microbial invasion of the joint synovial fluid in the stage IV. Clinical microbial intervention should consider the RA stage, where microbial dysbiosis and metabolic disorders present distinct patterns and played stage-specific roles. Our work provides a new insight in understanding gut–joint axis from a perspective of stages, which opens up new avenues for RA prognosis and therapy.
登录
查看更多内容
DOI:
10.1016/s0272-0590(82)80039-0
发表时间:
1982-07-01
期刊:
Fundamental and applied toxicology : official journal of the Society of Toxicology
影响因子:
--
作者:
Miller, R R;Carreon, R E;McKenna, M J
通讯作者:
McKenna, M J
影响因子:
7
作者:
Severmann AC;Jochmann K;Feller K;Bachvarova V;Piombo V;Stange R;Holzer T;Brachvogel B;Esko J;Pap T;Hoffmann D;Vortkamp A
通讯作者:
Vortkamp A
影响因子:
5.9
作者:
Carr AC;Maggini S
通讯作者:
Maggini S
影响因子:
4.9
作者:
Shamdani S;Chantepie S;Flageollet C;Henni-Chebra N;Jouan Y;Eymard F;Hay E;Cohen-Solal M;Papy-Garcia D;Chevalier X;Albanese P
通讯作者:
Albanese P
影响因子:
27.4
作者:
ABRAMS, E;SANDSON, J
通讯作者:
SANDSON, J